Showing results (1-10 of 3,131) with videos related to
Sort By:
Pageof 314
Pharmaceutical Statistics|October 24, 2024
PKBOIN-12: A Bayesian Optimal Interval Phase I/II Design Incorporating Pharmacokinetics Outcomes to Find the Optimal Biological DoseHao Sun, Jieqi TuJournal of Biopharmaceutical Statistics|December 4, 2025
TITE-STEIN: Time-to-event simple toxicity and efficacy interval design to accelerate phase I/II trialsHao Sun, Jieqi Tu, Revathi Ananthakrishnan, et al.Journal of Biopharmaceutical Statistics|November 17, 2024
Statistical operating characteristics of current early phase dose finding designs with toxicity and efficacy in oncologyHao Sun, Hsin-Yu Lin, Jieqi Tu, et al.Biometrical Journal. Biometrische Zeitschrift|December 4, 2023
Bayesian dose escalation with overdose and underdose control utilizing all toxicities in Phase I/II clinical trialsJieqi Tu, Zhengjia ChenStatistics in Medicine|November 29, 2022
Gaussian variational approximate inference for joint models of longitudinal biomarkers and a survival outcomeJieqi Tu, Jiehuan SunBiochimica Et Biophysica Acta. Molecular Basis of Disease|October 9, 2023
Exogenous recombinant N-acetylgalactosamine-4-sulfatase (Arylsulfatase B; ARSB) inhibits progression of B16F10 cutaneous melanomas and modulates cell signalingSumit Bhattacharyya, Insug O-Sullivan, Jieqi Tu, et al.Sensors (Basel, Switzerland)|July 12, 2025
Semi-Automated Processing of Harmonized Accelerometer and GPS Data in R: AGPSRNathan Tintle, Jieqi Tu, Anna Luong, et al.Frontiers in Public Health|January 21, 2026
Everyday environmental exposures and mid-life dietary and physical activity variations: E3 study protocolUlf G Bronas, Kiarri N Kershaw, Jieqi Tu, et al.Sensors (Basel, Switzerland)|March 28, 2026
Demographic Associations with GPS-Inferred Routine Activity Spaces: Data from the Everyday Environments and Experiences (E3) StudyNathan Ryder, Ulf G Bronas, Jason Westra, et al.Cancer Research|June 25, 2021
The Proteomic Landscape of Growth Factor Signaling Networks Associated with FAT1 Mutations in Head and Neck CancersZhengjia Chen, Chao Zhang, Jianhong Chen, et al.Pageof 314